VANCOUVER, British Columbia, Sept. 8, 2005 (PRIMEZONE) -- Meridian Co., Ltd. (Meridian) (OTCBB:MRDAF) today announced that it has successfully negotiated the sale of 300 units of its proprietary Lipo-laser product representing over $1,000,000 in revenue to the company of which $650,000 has already been deposited. The units will be delivered between September and October and represent the first major transaction involving the Lipo-laser group of products.
It is anticipated that Meridian will sell over 2,000 units over the next year representing over $10,000,000 in gross sales to the company from this single product.
"The market reaction for the Lipo-laser is enormous prior to the product being formally introduced to the marketplace. For this particular order, all the units have been reserved or pre-sold, indicating the insatiable demand for the Lipo-laser," said Hyeon Seong Myeong, the company's president.
The patented Lipo-laser's non-invasive treatment is considered one of the most innovative methods to liquify adipose tissue. The demand for this type of treatment is expected to grow rapidly not only in the plastic surgery profession but in any clinical setting that treats obesity such as spas and wellness centers.
About Meridian
Meridian is an established leader in the research/development, manufacturing and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and it has received FDA as well as other international regulatory approvals for many of its products.
Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.
This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the company.
HTML: http://newsroom.eworldwire.com/wr/090805/12576.htm PDF: http://newsroom.eworldwire.com/pdf/090805/12576.pdf ONLINE NEWSROOM: http://newsroom.eworldwire.com/307280.htm LOGO: http://newsroom.eworldwire.com/307280.htm